Why the study?
How does the in-vivo sensitivity of aPTT reagents to heparin compare to in-vitro sensitivity, and what are the implications for the therapeutic range?
Design
Other
Authors
Loading...
May require reagent-specific aPTT ranges for heparin; leaves open prospective validation of clinical outcomes.
How does the in-vivo sensitivity of aPTT reagents to heparin compare to in-vitro sensitivity, and what are the implications for the therapeutic range?
Highlights the variability in aPTT reagent sensitivity to heparin, emphasizing that a universal 1.5-2.5x therapeutic range is inappropriate for all reagents.
Bain et al. (1980) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: